Briacell Therapeutics Corp BCTX

$3.01 -0.08 (-2.59%)

Valuation

Market cap
26,546,000
Revenue TTM
$0
Net income TTM
$-26,310,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
52,806
Avg volume
301,996
Day's range
$2.98 – $3.18
Shares out
8,732,000
Stochastic %K
19%
Beta
1.21
Analysts
—
Price target
$40.00

Price

Company profile

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator...

Show more

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate the clinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.

Industry
Biotechnology
Sector
Healthcare
Phone
604 921 1810
Website
https://briacell.com
Address
Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada

Latest news

Stocktwits

smallpower17 Nov 3, 9:13 PM
$BCTX Interesting that BriaCell did their last Renmark presentation on Sept 29 and they are already going to do another one on Nov 12. Seems like a very bullish signal to me. About to get exciting!
0 replies
AliceFireSteam Nov 3, 9:05 PM
$BCTX added, 6800 shares now, thanks for the drop
0 replies
SmallCapGrowth Nov 3, 6:32 PM
$BCTX and BriaPro will showcase 4 preclinical presentations at #SITC2026, highlighting anti-cancer activity across breast, prostate and lung cancer models. Data further supports the potential of Bria-OTS+™ and next-generation immunotherapy programs. News: https://bit.ly/4A9Lfir
0 replies
Merlintrader Nov 3, 5:53 PM
BriaCell $BCTX will present four posters at SITC. The posters are set for Nov 6 and Nov 7. Shares closed at $3.09 on Monday, below the SMA50 and below the SMA200, RSI 33. More details in our hub. Not investment advice.
0 replies
SmallCapGrowth Nov 3, 5:29 PM
MOMO'S BREAKOUT BOARD : BriaCell $BCTX and subsidiary BriaPro wi... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=178101252 via @Investors_Hub
0 replies
SmallCapGrowth Nov 3, 5:20 PM
BriaCell $BCTX is expanding its immunotherapy platform with multiple programs generating preclinical data across diverse cancer indications. Four presentations at #SITC2026 underscore the depth of the pipeline and future development opportunities. News: https://bit.ly/4A9Lfir
0 replies
SmallCapGrowth Nov 3, 4:50 PM
BriaCell $BCTX is expanding its immunotherapy platform with multiple programs generating preclinical data across diverse cancer indications. Four presentations at #SITC2026 underscore the depth of the pipeline and future development opportunities. News: https://bit.ly/4A9Lfir
0 replies
SmallCapGrowth Nov 3, 4:37 PM
Momentum Players : BriaCell $BCTX is expanding its immunoth... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=178101289 via @Investors_Hub
0 replies